We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How we assess issues of potential regulatory concern
Introducing the new pre-application service for Nationally Significant Infrastructure Projects.
Guidance for manufacturers of cardiac implantable electronic devices and their leads. It outlines specific scenarios that should be considered when determining if an incident is reportable.
How to use an interrupted time series to evaluate your digital health product.
Guidance on the pre-application stage for Nationally Significant Infrastructure Projects.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Provides guiding principles on how planning can deal with land affected by contamination.
How investigators and sponsors should manage clinical trials during COVID-19
Information on how the CMA investigated the merger, and how you can find out more.
Guidance primarily aimed at local responders covering some common issues that may arise during the Recovery Phase of an emergency in the UK.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).